These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 24657660)

  • 1. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
    Wu Q; Yang Z; Nie Y; Shi Y; Fan D
    Cancer Lett; 2014 Jun; 347(2):159-66. PubMed ID: 24657660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer.
    Zeng X; Wang HY; Bai SY; Pu K; Wang YP; Zhou YN
    Curr Mol Med; 2020; 20(9):667-674. PubMed ID: 32209033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways involved in microRNA-mediated regulation of multidrug resistance.
    Liao R; Lin Y; Zhu L
    Mol Biol Rep; 2018 Dec; 45(6):2913-2923. PubMed ID: 30194558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and multidrug resistance in cancer.
    Li YJ; Lei YH; Yao N; Wang CR; Hu N; Ye WC; Zhang DM; Chen ZS
    Chin J Cancer; 2017 Jun; 36(1):52. PubMed ID: 28646911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.
    Hong L; Han Y; Zhang Y; Zhang H; Zhao Q; Wu K; Fan D
    Expert Opin Ther Targets; 2013 Sep; 17(9):1073-80. PubMed ID: 23865553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection approaches for multidrug resistance genes of leukemia.
    Du Y; Chen B
    Drug Des Devel Ther; 2017; 11():1255-1261. PubMed ID: 28458519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of expression of multidrug resistance gene in breast cancer tissue].
    Liu X; Song S; Shi C
    Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):488-90. PubMed ID: 9772445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
    Xie L; Jing R; Qi J; Lin Z; Ju S
    Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
    Zhang D; Fan D
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer.
    Wu Y; Yang X; Xie Z; Hu H; Lei X; Niu D; Li S; Tuo L
    Comb Chem High Throughput Screen; 2022; 25(13):2127-2140. PubMed ID: 35366768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation.
    Xia CQ; Smith PG
    Mol Pharmacol; 2012 Dec; 82(6):1008-21. PubMed ID: 22826468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
    Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
    Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.